FasII and DpMAPK immunoreactivity levels at larval NMJs with altered MAPKinase activity
| Anti-dpMAPK (n) | Anti-FasII (n) | |
|---|---|---|
| CS | 143 ± 5 (65) | 106 ± 3 (80) |
| rl10a/+ | 102 ± 4 (66) | 135 ± 3 (68) |
| rlSEM/+ | 194 ± 6 (59) | 80 ± 2 (84) |
Numbers in parentheses represent the number of scored boutons out of ∼20 preparations for each genotype and antibody.